COGNICURRENT

Feb 4 • 08:49 UTC • 🇩🇰 Denmark • Politiken

Novo-chef: We are affected by two factors pulling in the wrong direction

Novo Nordisk anticipates a 5 to 13 percent decline in sales by 2026 due to two specific negative factors despite expecting continued demand for its medicines, as explained by CEO Mike Doustdar during a teleconference following the 2025 financial report.

#novo nordisk #mike doustdar #sales decline #medicine demand #financial report

Read Original Back to Feed

📡 Similar Coverage

🇩🇰 Denmark Feb 4 • 08:49 UTC

Novo-chef: We are affected by two factors that pull in the wrong direction

Politiken

🇩🇰 Denmark Feb 3 • 17:17 UTC

Dismal prediction: If Novo is right, 2026 could become the company's worst year in this millennium

Politiken

🇩🇰 Denmark Feb 4 • 08:06 UTC

Novo Nordisk in a bloodbath on the stock market

Politiken

🇩🇰 Denmark Feb 3 • 17:17 UTC

Dismal prediction: If Novo is correct, 2026 could be the worst year of this millennium

Politiken

🇩🇪 Germany Feb 4 • 13:17 UTC

"The market is relatively saturated - we see no big growth prospects anymore"

Die Welt

🇬🇷 Greece Feb 4 • 08:35 UTC

Novo Nordisk: 18% 'plunge' in stocks after the 'cold shower' for 2026 forecasts

Naftemporiki